title: The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia.
authors.forename: Naondo
authors.initials: N
authors.lastname: Sohara
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Takagi
authors.forename: Satoru
authors.initials: S
authors.lastname: Kakizaki
authors.forename: Ken
authors.initials: K
authors.lastname: Sato
authors.forename: Masatomo
authors.initials: M
authors.lastname: Mori
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D002779:Cholestasis / Q000150:complications*; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D006526:Hepatitis C / Q000150:complications* / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods*; D008875:Middle Aged; D012254:Ribavirin / Q000494:pharmacology*; D013156:Splenectomy; D013157:Splenic Artery / Q000473:pathology*; D013921:Thrombocytopenia / Q000150:complications* / Q000628:therapy
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons